OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer
Naohiro Fujimoto, Yuto Tsubonuma, Yujiro Nagata, et al.
Anticancer Research (2023) Vol. 43, Iss. 9, pp. 3841-3847
Open Access | Times Cited: 8
Naohiro Fujimoto, Yuto Tsubonuma, Yujiro Nagata, et al.
Anticancer Research (2023) Vol. 43, Iss. 9, pp. 3841-3847
Open Access | Times Cited: 8
Showing 8 citing articles:
Prostate Cancer: A Journey Through Its History and Recent Developments
Hamza Mallah, Zania Diabasana, Sina Soultani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 194-194
Open Access
Hamza Mallah, Zania Diabasana, Sina Soultani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 194-194
Open Access
Das metastasierte Prostatakarzinom: Therapieoptionen
Eva Erne, Max-Felix Häring, Elgin Hoffmann
Onkologische Welt (2025) Vol. 16, Iss. 02, pp. 93-98
Closed Access
Eva Erne, Max-Felix Häring, Elgin Hoffmann
Onkologische Welt (2025) Vol. 16, Iss. 02, pp. 93-98
Closed Access
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate
Haley Meyer, Rajitha Sunkara, Emily Rothmann, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 5, pp. 102172-102172
Closed Access | Times Cited: 2
Haley Meyer, Rajitha Sunkara, Emily Rothmann, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 5, pp. 102172-102172
Closed Access | Times Cited: 2
Lethal disseminated intravascular coagulation induced by primary and metastatic neuroendocrine prostate cancer
Takashi Ando, Taro Sasaki, Makoto Naito
IJU Case Reports (2024) Vol. 7, Iss. 3, pp. 238-242
Open Access
Takashi Ando, Taro Sasaki, Makoto Naito
IJU Case Reports (2024) Vol. 7, Iss. 3, pp. 238-242
Open Access
A case of mixed neuroendocrine carcinoma–acinar adenocarcinoma: Utilization of triplet therapy for prostate cancer
Junichi Ikeda, Hisanori Taniguchi, Hiroki Takayama, et al.
IJU Case Reports (2024) Vol. 7, Iss. 6, pp. 459-462
Open Access
Junichi Ikeda, Hisanori Taniguchi, Hiroki Takayama, et al.
IJU Case Reports (2024) Vol. 7, Iss. 6, pp. 459-462
Open Access
A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrine Prostate Cancer: Case Report and Review of the Literature
Helena Ferreira Bruzzi Porto, Gabriela Carreiro Kubitschek Lopes, Hannah Barboza Vianna Bekierman, et al.
Case Reports in Oncology (2024) Vol. 17, Iss. 1, pp. 950-959
Open Access
Helena Ferreira Bruzzi Porto, Gabriela Carreiro Kubitschek Lopes, Hannah Barboza Vianna Bekierman, et al.
Case Reports in Oncology (2024) Vol. 17, Iss. 1, pp. 950-959
Open Access
Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer
Weijie Zhang, Adam M. Lee, L.J. Lee, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 9
Open Access
Weijie Zhang, Adam M. Lee, L.J. Lee, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 9
Open Access
Das metastasierte Prostatakarzinom: Therapieoptionen
Eva Erne, Max-Felix Häring, Elgin Hoffmann
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 08, pp. 522-526
Closed Access
Eva Erne, Max-Felix Häring, Elgin Hoffmann
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 08, pp. 522-526
Closed Access
